Discover Tenders by Currency Vending Or Dispenser Machinecashnotechequecoin Sector

Find the most relevant tenders for Currency Vending Or Dispenser Machinecashnotechequecoin. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Currency Vending Or Dispenser Machinecashnotechequecoin tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Currency Vending Or Dispenser Machinecashnotechequecoin tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Orylmyte Atc Code According To Who V01Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 6173952

EMD:Ref Document

Bid Value: Ref Document

441 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Itulazax Atc Code According To Who V01Aa05

Deadline: 31 Jul 2026

Germany

Ref. No.: 6171828

EMD:Ref Document

Bid Value: Ref Document

441 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Fentanyl In The Dosage Form Of Sublingual Tablets Atc Code According To Wh

Deadline: 30 Jun 2026

Germany

Ref. No.: 6165516

EMD:Ref Document

Bid Value: Ref Document

410 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Ustekinumab Atc Code According To Who L04Ac05

Deadline: 31 Jul 2025

Germany

Ref. No.: 6164864

EMD:Ref Document

Bid Value: Ref Document

76 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ustekinumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 6108284

EMD:Ref Document

Bid Value: Ref Document

451 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Lisdexamfetamine

Deadline: 10 Nov 2025

Germany

Ref. No.: 6072974

EMD:Ref Document

Bid Value: Ref Document

178 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Epinephrine In The Dosage Form Ilo

Deadline: 10 May 2026

Germany

Ref. No.: 5978859

EMD:Ref Document

Bid Value: Ref Document

359 Days Left

Conclusion Not Exclusive Of Am Discount Agreement According To Section 130A Paragraph 8 Sgb V By Means Of An Oh Model For Ws Epoetin Alfa Genetically Engineered Human Erythropoietin Restriction To Packs With Doses Up To 10 000 Iu

Deadline: 31 Jul 2026

Germany

Ref. No.: 5978748

EMD:Ref Document

Bid Value: Ref Document

441 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Filgrastim Atc Code According To Who L03Aa02

Deadline: 30 Jun 2026

Germany

Ref. No.: 5978377

EMD:Ref Document

Bid Value: Ref Document

410 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ebastine In The Strength 20 Mg And The Dosage Form Smt

Deadline: 10 May 2026

Germany

Ref. No.: 5978310

EMD:Ref Document

Bid Value: Ref Document

359 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Somatropin Atc Code According To Who H01Ac01

Deadline: 31 Jul 2026

Germany

Ref. No.: 5977915

EMD:Ref Document

Bid Value: Ref Document

441 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brimonidine In The Dosage Form Edp

Deadline: 10 May 2026

Germany

Ref. No.: 5977462

EMD:Ref Document

Bid Value: Ref Document

359 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

Deadline: 10 May 2026

Germany

Ref. No.: 5976401

EMD:Ref Document

Bid Value: Ref Document

359 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of A So Called Open House Model For Medicinal Products With The Trade Name Acarizax R Atc Code According To Who V01Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 5975947

EMD:Ref Document

Bid Value: Ref Document

441 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Pegfilgrastim Atc Code According To Who L03Aa13

Deadline: 30 Apr 2026

Germany

Ref. No.: 5975224

EMD:Ref Document

Bid Value: Ref Document

349 Days Left

Showing 1996 to 2010 of 2032 results

Discover Tenders by Currency Vending Or Dispenser Machinecashnotechequecoin Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Currency Vending Or Dispenser Machinecashnotechequecoin Sector

Filter Your Search

FREE Trial plan for all new users!